30 April 2024 - A new cancer treatment recently approved in Canada promises to cut treatment time down to just ...
26 March 2024 - We describe temporal trends in expenditure on cancer medicines within the single-payer health system of Ontario, Canada, ...
21 December 2023 - Merck and Eisai announce that Keytruda plus Lenvima, is now reimbursed with clinical criteria and conditions ...
25 October 2023 - Merck and Eisai announced today that Keytruda, an anti-PD-1 therapy, in combination with Lenvima, the multiple receptor ...
29 September 2023 - Medison Pharma is pleased to announce the public formulary listing of Qinlock in Canadian provinces: Ontario ...
17 August 2023 - This is the first public listing since Minjuvi was approved with conditions by Health Canada in ...
2 August 2023 - Jazz Pharmaceuticals today announced that the Company has entered into a letter of intent with the pan-Canadian ...
10 July 2023 - Health technology assessment agencies reinforce the therapeutic value of Pluvicto and need for new approaches to treat ...
24 May 2023 - The pCPA agreement will support the public listings and reimbursement of Xpovio. ...
6 April 2023 - This CADTH recommendation is a step towards public access to Rybrevant as a targeted therapy for ...
6 February 2023 - First and only Bruton's tyrosine kinase inhibitor to be granted provincial formulary approval. ...
6 December 2022 - BC is the third province to add Tukysa to its provincial dormulary. ...
1 November 2022 - Lilly Canada announced today that CADTH has issued their final reimbursement recommendation for Verzenio (abemaciclib) in ...
25 October 2022 - Health technology assessment can be used to make healthcare systems more equitable and efficient. Advances in precision ...
10 October 2022 - Four years ago, Ontarian Rebecca Grundy got a nightmare diagnosis that sent her into a blind ...